These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 14439602)

  • 21. [Favorable effects of prednisolone (deltacortril) in a case of progressive diffuse scleroderma].
    WIEME RJ
    Belg Tijdschr Geneesk; 1956 May; 12(9):504-6. PubMed ID: 13328782
    [No Abstract]   [Full Text] [Related]  

  • 22. [Early results of Wulzen anti-stiffness factor in therapy of scleroderma].
    THIERS H
    J Med Lyon; 1953 Jul; 34(805):589-90. PubMed ID: 13085101
    [No Abstract]   [Full Text] [Related]  

  • 23. [Scleroderma diffusa and its treatment].
    GOHRBANDT E
    Dtsch Gesundheitsw; 1948 Sep; 3(18):548-50. PubMed ID: 18104064
    [No Abstract]   [Full Text] [Related]  

  • 24. [Effect of cytochrome C in scleroderma and in sclerodactylia].
    BINAZZI M
    Rass Dermatol Sifilogr; 1952; 5(3):145-8. PubMed ID: 13027595
    [No Abstract]   [Full Text] [Related]  

  • 25. Use of relaxin in the treatment of scleroderma.
    CASTEN GG; BOUCEK RJ
    J Am Med Assoc; 1958 Jan; 166(4):319-24. PubMed ID: 13491339
    [No Abstract]   [Full Text] [Related]  

  • 26. Complete subsidence of scleroderma with dihydrotachysterol.
    BERNSTEIN ET; GOLDBERGER LA
    J Am Med Assoc; 1946 Mar; 130():570. PubMed ID: 21013660
    [No Abstract]   [Full Text] [Related]  

  • 27. [On the therapy of systematized scleropathy (progressive scleroderma) and systematized sarcoidosis with the chelating agent Na2EDTA].
    LANGHOF H; ZABEL H
    Dtsch Gesundheitsw; 1962 Feb; 17():188-97. PubMed ID: 14462154
    [No Abstract]   [Full Text] [Related]  

  • 28. Use of hyaluronidase in scleroderma.
    CLAESSON U; LINDQUIST B
    Acta Paediatr (Stockh); 1953 May; 42(3):278-81. PubMed ID: 13079763
    [No Abstract]   [Full Text] [Related]  

  • 29. [Distant results of surgical treatment of scleroderma].
    LERICHE R
    Sem Med; 1949 Jul; 56(28):63-70. PubMed ID: 18136615
    [No Abstract]   [Full Text] [Related]  

  • 30. Relaxin (releasin) therapy in diffuse progressive scleroderma; a preliminary report.
    EVANS JA
    AMA Arch Derm; 1959 Feb; 79(2):150-8. PubMed ID: 13616712
    [No Abstract]   [Full Text] [Related]  

  • 31. [Progressive scleroderma with considerable electromyographical changes treated with chelating agents (E.D.T.A.)].
    da FONSECA
    J Med (Oporto); 1960 Feb; 41():469-76. PubMed ID: 13823810
    [No Abstract]   [Full Text] [Related]  

  • 32. [Sclerodactyly and scleroderma treated with parathyroidectomy].
    MIDANA A
    Dermosifilografo (Torino); 1949 Mar; 24(3):125-7. PubMed ID: 18144465
    [No Abstract]   [Full Text] [Related]  

  • 33. [Hyaluronidase in scleroderma].
    JOHANSSON S; MOLLER F
    Nord Med; 1957 Jul; 58(30):1086-9. PubMed ID: 13465029
    [No Abstract]   [Full Text] [Related]  

  • 34. [Atrioventricular conduction disorders in a scleroderma treated with vitamin D2].
    SONZINI ASTUDILLO S
    Rev Asoc Med Argent; 1948 Oct; 62(640):584-90. PubMed ID: 18103618
    [No Abstract]   [Full Text] [Related]  

  • 35. [A case of edematous scleroderma with joint manifestations transformed by methionine].
    BINET L; BOUR H; TANRET P
    Prog Med (Paris); 1948 Sep; 76(17):419-21. PubMed ID: 18883588
    [No Abstract]   [Full Text] [Related]  

  • 36. Role of ultrasound in scleroderma; a preliminary report on two cases.
    TUCHMAN LS
    Am J Phys Med; 1956 Apr; 35(2):118-24. PubMed ID: 13313734
    [No Abstract]   [Full Text] [Related]  

  • 37. A technique for intravenous therapy in patients with scleroderma and in apprehensive children.
    LUNDY JS
    AMA Arch Derm; 1959 Aug; 80(2):226-7. PubMed ID: 13669755
    [No Abstract]   [Full Text] [Related]  

  • 38. [Successful treatment with vitamin D2 of 3 patients with scleroderma].
    ALIBEKOV SIu; KHALILOV KhM
    Vestn Dermatol Venerol; 1962 Feb; 36():69-71. PubMed ID: 13860420
    [No Abstract]   [Full Text] [Related]  

  • 39. The treatment of scleroderma with the new chelating agent, edathamil.
    MULLER SA; BRUNSTING LA; WINKELMANN RK
    AMA Arch Derm; 1959 Aug; 80(2):187-94. PubMed ID: 13669744
    [No Abstract]   [Full Text] [Related]  

  • 40. [Scleroderma; Sclerodactyly; Active chronic polyarthritis; Total cure by a specific treatment].
    FEROND
    Brux Med; 1947 Jun; 27(23):1285-9. PubMed ID: 20261228
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.